Biological response modifiers in rheumatoid arthritis.
Kassimos
D
D
Mitton
D
D
Whallett
A
A
Delamere
J P
JP
Kitas
G D
GD
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage*; D007155:Immunologic Factors / Q000008:administration & dosage*; D000069285:Infliximab; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage*; D012646:Self Administration; D016896:Treatment Outcome; D014481:United States
D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D007155:Immunologic Factors; D018124:Receptors, Tumor Necrosis Factor; D000069285:Infliximab; D000068800:Etanercept